Screening and identification of human phage displayed scFv antibody against ATP-binding cassette sub-family G member 2 of lung adenocarcinoma

赵文思; 罗弋; 黎博一; 张涛

您当前的位置：

首页 >

文章列表页 >

Screening and identification of human phage displayed scFv antibody against ATP-binding cassette sub-family G member 2 of lung adenocarcinoma

更新时间：2026-01-09

- Screening and identification of human phage displayed scFv antibody against ATP-binding cassette sub-family G member 2 of lung adenocarcinoma
- Journal of Army Medical University Vol. 37, Issue 23, Pages: 2343-2347(2015)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R392-33;R392.11;R734.2
- Published：2015
- 稿件说明：
移动端阅览
赵文思,罗弋,黎博一,张涛.三磷酸腺苷结合转运蛋白G超家族成员2特异性人源肺癌噬菌体单链抗体的筛选和鉴定[J].陆军军医大学学报(原第三军医大学学报),2015,37(23):2343-2347.

　Zhao Wensi,Luo Yi,Li Boyi,Zhang Tao.Screening and identification of human phage displayed scFv antibody against ATP-binding cassette sub-family G member 2 of lung adenocarcinoma[J].J Amry Med Univ (J Third Mil Med Univ),2015,37(23):2343-2347.
赵文思,罗弋,黎博一,张涛.三磷酸腺苷结合转运蛋白G超家族成员2特异性人源肺癌噬菌体单链抗体的筛选和鉴定[J].陆军军医大学学报(原第三军医大学学报),2015,37(23):2343-2347. DOI：

　Zhao Wensi,Luo Yi,Li Boyi,Zhang Tao.Screening and identification of human phage displayed scFv antibody against ATP-binding cassette sub-family G member 2 of lung adenocarcinoma[J].J Amry Med Univ (J Third Mil Med Univ),2015,37(23):2343-2347. DOI：

摘要

目的通过噬菌体展示库技术构建人肺癌单链抗体库，并筛选出抗多药耐药蛋白ABCG2的特异性单链抗体。方法取肺腺癌患者癌旁阳性淋巴结提RNA，PCR扩增重链和轻链可变区基因VH、VL，SOE-PCR扩增单链抗体可变区基因scFv，克隆入噬菌体表达载体pCANTAB5E，制备初级抗体库。以A549细胞及ABCG2蛋白对抗体库进行6轮淘选。Western blot检测单链抗体的可溶性表达和对ABCG2蛋白表达的影响，ELISA和ICC鉴定其特异性，CCK-8检测其顺铂增敏作用。结果成功筛选出抗ABCG2人源肺腺癌噬菌体单链抗体。Western blot证实其可溶性表达，大小约为34×10

且可明显下调ABCG2蛋白的表达。ELISA和ICC检测到该抗体对ABCG2抗原的识别率高达75%，并与A549细胞具有结合特异性。CCK8结果则显示该scFv可增加A549细胞对顺铂的敏感性，明显减小其IC

值。结论成功构建了人源肺腺癌噬菌体单链抗体库，并筛选出了能与ABCG2蛋白特异性结合的单链抗体，为后续体内可视化研究和靶向ABCG2

的肺癌干样细胞奠定基础。

Abstract

Objective To construct a phage display library and screen phage-displayed single-chain variable fragment (scFv) antibody against ATP-binding cassette sub-family G member 2 (ABCG2) of lung adenocarcinoma. Methods Total RNA of positive lymph nodes adjacent to lung adenocarcinoma was extracted. Variable regions of heavy (VH) and light chain (VL) were amplified by PCR. ScFv gene was synthesized by SOE-PCR

and then linked to a pCANTAB5E phagemid vector to finally creat

e a phage displayed scFv library. Six rounds of biopanning against A549 cells and ABCG2 antigen were performed. The properties of the product were identified by Western blotting

and its specificity was detected by ELISA and immunocytochemical assay. CCK8 assay was used to detect its effect on cisplatinsensitization. Results A phage displayed scFv antibody against ABCG2 of lung cancer was successfully constructed. The obtained scFv antibody had an apparent molecular weight of 34×10

and significantly down-regulated the expression of ABCG2 protein in A549 cells. Besides

it demonstrated a relative specific affinity to A549 cells and ABCG2 antigen with a positive recognition rate of 75%. Furthermore

it increased the cisplatin sensitivity in A549 cells with distinctly reduced IC

values. Conclusion A phage displayed anti-ABCG2 scFv of lung cancer is successfully constructed

and through it

scFv antibody is screen out which can specifically bind to single-chain antibodies. This study found a strong basis for subsequent body visualization research and lung cancer stem-like cells targeting ABCG2.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Emerging advances in clinical diagnosis and treatment of hepatocellular carcinoma: evolution of comprehensive treatment strategies

Efficacy and safety of immunotherapy combined with targeted therapy and chemotherapy in third-line treatment of microsatellite stable metastatic colorectal cancer

Screening and validation of tsRNAs associated with lung adenocarcinoma

Prognostic prediction of lung adenocarcinoma based on transcriptomic data and stacked supervised autoencoder

Clinical characteristics and survival analysis of rare mutations in locally advanced or metastatic lung adenocarcinoma

Related Author

LI Jianwei

WANG Xingru

ZHAO Wensi

SONG Jian

LU Chunli

SHAN Yifan

XIE Weijia

XIA Tingting

Related Institution

Institute of Hepatobiliary Surgery of PLA，First Affiliated Hospital， Army Medical University （Third Military Medical University）

No.953，Xigaze， Tibet Autonomous Region

Department of Oncology, Renmin Hospital of Wuhan University

Department of Pharmacy, Renmin Hospital of Wuhan University

Department of Epidemiology， Faculty of Military Preventive Medicine， Army Medical University （Third Military Medical University）， Chongqing, PLA Key Laboratory of Respiratory Diseases， Second Affiliated Hospital， Army Medical University （Third Military Medical University）

⁰